ETFs Holding iShares Genomics Immunology and Healthcare ETF (IDNA)
Symbol
Name
Exchange
IDNA's Weight
Expense Ratio
Price(Change)
Market Cap
no data
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IDNA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
